Theralink Technologies Inc (THER)

[drugmanrx]

So what's 5 billion shares.

You knew all along that there would be 100 to 1000 to 1 RS split before they had a product to market.

The only question is what will the market cap be if indeed they do have a vaccine for prostate and or ovarian cancer.

10 million, 100 million, 1 billion, 5 billion, 10-20-30 billion?

IMHO, I would expect it to be in the later range.

If so then today stock will be over a dollar even with dilution.

Just for men over 70 on medicare

Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.

https://www.ncbi.nlm.nih.gov/pubmed/30242397

"The estimated total 3-year cost to the Medicare program associated with the annual detection of prostate cancer in men 70 years or older is approximately $1.2 billion. Increasing active surveillance use in those with Gleason score of 6 or lower could reduce this cost by $320 million."


Cost of Care for the Initial Management of Ovarian Cancer

https://journals.lww.com/greenjournal/FullText/2017/12000/Cost_of_Care_for_the_Initial_Management_of_Ovarian.12.aspx

"The average cost of care for women with ovarian cancer in the first year after surgery is approximately $100,000. Patients bear approximately 3% of these costs in the form of out-of-pocket expenses."

"About 21,000 U.S. people get diagnosed with ovarian cancer every year, and about 14,000 die from it. An individual's lifetime risk of developing ovarian cancer is about 1 in 78"